Mitsubishi UFJ Asset Management UK Ltd. Buys 4,000 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)

Mitsubishi UFJ Asset Management UK Ltd. boosted its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 200.0% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 6,000 shares of the medical instruments supplier’s stock after purchasing an additional 4,000 shares during the period. West Pharmaceutical Services comprises about 0.9% of Mitsubishi UFJ Asset Management UK Ltd.’s investment portfolio, making the stock its 26th biggest position. Mitsubishi UFJ Asset Management UK Ltd.’s holdings in West Pharmaceutical Services were worth $1,801,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Sumitomo Mitsui Trust Holdings Inc. raised its position in shares of West Pharmaceutical Services by 1.5% during the 1st quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 191,469 shares of the medical instruments supplier’s stock valued at $75,766,000 after purchasing an additional 2,759 shares during the period. Mizuho Markets Americas LLC lifted its position in shares of West Pharmaceutical Services by 142.3% in the first quarter. Mizuho Markets Americas LLC now owns 29,628 shares of the medical instruments supplier’s stock valued at $11,724,000 after acquiring an additional 17,399 shares in the last quarter. AMI Asset Management Corp boosted its stake in shares of West Pharmaceutical Services by 3.3% in the first quarter. AMI Asset Management Corp now owns 164,738 shares of the medical instruments supplier’s stock worth $65,188,000 after acquiring an additional 5,217 shares during the period. Tidal Investments LLC raised its stake in West Pharmaceutical Services by 54.7% during the 1st quarter. Tidal Investments LLC now owns 10,574 shares of the medical instruments supplier’s stock valued at $4,181,000 after purchasing an additional 3,738 shares during the period. Finally, SG Americas Securities LLC lifted its holdings in West Pharmaceutical Services by 44.4% in the 1st quarter. SG Americas Securities LLC now owns 12,365 shares of the medical instruments supplier’s stock worth $4,893,000 after purchasing an additional 3,802 shares in the last quarter. Hedge funds and other institutional investors own 93.90% of the company’s stock.

West Pharmaceutical Services Price Performance

WST traded up $4.66 during trading on Friday, reaching $293.32. 640,174 shares of the company traded hands, compared to its average volume of 551,886. West Pharmaceutical Services, Inc. has a 12-month low of $265.00 and a 12-month high of $413.70. The firm has a fifty day simple moving average of $299.96 and a 200 day simple moving average of $325.39. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.68 and a current ratio of 2.34. The company has a market cap of $21.37 billion, a P/E ratio of 38.70, a PEG ratio of 10.53 and a beta of 1.01.

West Pharmaceutical Services (NYSE:WST) last issued its earnings results on Thursday, July 25th. The medical instruments supplier reported $1.52 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.74 by ($0.22). West Pharmaceutical Services had a return on equity of 19.17% and a net margin of 18.25%. The firm had revenue of $702.10 million during the quarter, compared to the consensus estimate of $729.36 million. During the same period last year, the firm posted $2.11 earnings per share. The company’s revenue for the quarter was down 6.9% compared to the same quarter last year. On average, equities analysts forecast that West Pharmaceutical Services, Inc. will post 6.42 EPS for the current year.

Insiders Place Their Bets

In other news, VP Charles Witherspoon sold 1,029 shares of the stock in a transaction on Monday, August 19th. The stock was sold at an average price of $300.00, for a total transaction of $308,700.00. Following the transaction, the vice president now owns 1,478 shares of the company’s stock, valued at approximately $443,400. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.53% of the stock is currently owned by company insiders.

West Pharmaceutical Services Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.